home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Shutting the Door on Obesity

  March, 23 2009 4:09
your information resource in human molecular genetics

Knocking out an enzyme responsible for the metabolism of fat in the intestine protects mice from obesity, reports research published online in Nature Medicine. The findings suggest a possible new target for reducing obesity.

Humans are efficient in absorbing fat within their diet and assimilating it into adipose tissue for the storage of energy. Although this ability suggests an advantage in times of calorie deprivation, it contributes to obesity when dietary fat is abundant. Robert Farese, Jr., and his colleagues show that the intestinal enzyme MGAT2 is crucial for the buildup of fat in mice.

They find that the absence of MGAT2 protects mice on a high-fat diet against developing obesity, high cholesterol and fatty liver. Although food intake and fat absorption are normal in MGAT2-deficient mice, entry of dietary fat into the circulation is reduced, favoring the partitioning of fat toward energy dissipation instead of towards storage in the adipose tissue.

As MGAT2 is an intestinal enzyme that can, in principle, be readily accessible to pharmacological inhibition, these results point to a new target in the fight against obesity that may have medical potential before long.

Author Contact:

Robert Farese, Jr. (University of California, San Francisco, CA, USA)
E-mail: bfarese@gladstone.ucsf.edu

Abstract available online.

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.